rs7571842 — SLC4A5

Salt Sensitivity and the Kidney's Sodium-Bicarbonate Transporter

Your kidneys decide whether blood pressure rises or stays stable on a high-salt diet. A key player in that decision is NBCe2¹¹ NBCe2
sodium-bicarbonate cotransporter electrogenic family member 2, encoded by the SLC4A5 gene in the proximal tubule. NBCe2 normally sits quietly in the Golgi apparatus, but when intracellular sodium climbs — as it does when you eat a salty meal — the transporter migrates to the apical membrane and accelerates coupled sodium-bicarbonate reabsorption back into the bloodstream. rs7571842 sits in an intron of SLC4A5 and modifies how aggressively this mechanism operates.

The Mechanism

Under high-sodium conditions, the rs7571842 A allele increases binding of HNF4A²² HNF4A
hepatocyte nuclear factor 4-alpha, a transcription factor that regulates metabolic genes in the liver and kidney to the SLC4A5 locus. This aberrant HNF4A-mediated upregulation enhances NBCe2 surface expression and activity in the proximal tubule, driving greater sodium reabsorption. The net result: more sodium retained, higher plasma volume, and amplified blood pressure on high-sodium diets. The G allele is associated with attenuated transporter expression and a blunted blood pressure response to sodium loading.

The Evidence

The foundational study by Carey RM et al.³³ Carey RM et al.
"Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter." Hypertension, 2012 put 185 white participants through a controlled dietary protocol (7 days at 10 mmol/day sodium, 7 days at 300 mmol/day) and found rs7571842 was one of the strongest genetic predictors of salt sensitivity, with the G allele conferring protection (OR=0.221, P=1.0×10⁻⁴). The finding replicated in an independent hypertensive cohort, with meta-analysis confirming the association (P=1.2×10⁻⁵).

A smaller controlled trial by Pilic & Mavrommatis⁴⁴ Pilic & Mavrommatis
"Genetic predisposition to salt-sensitive normotension and its effects on salt taste perception and intake." British Journal of Nutrition, 2018 quantified the effect in normotensive individuals: AA carriers showed the largest blood pressure increase on high sodium — +7.75 mmHg systolic (P=0.002, Cohen's d=2.4) and +6.25 mmHg diastolic (P=0.044) — a clinically meaningful difference. The mechanistic basis was confirmed by Gildea JJ et al.⁵⁵ Gildea JJ et al.
"Sodium bicarbonate cotransporter NBCe2 gene variants increase sodium and bicarbonate transport in human renal proximal tubule cells." PLoS One, 2018, who demonstrated that cells carrying the variant showed significantly greater bicarbonate- dependent pH recovery and sodium transport.

Earlier work in the HERITAGE Family Study (Stütz AM et al.⁶⁶ Stütz AM et al.
"Functional identification of the promoter of SLC4A5, a gene associated with cardiovascular and metabolic phenotypes." European Journal of Human Genetics, 2009) found rs7571842 associated with resting and submaximal exercise pulse pressure (P=0.002–0.003) in 503 White participants, extending the finding beyond resting blood pressure.

Practical Actions

Salt sensitivity affects an estimated 25–30% of the adult population and is a major contributor to hypertension that does not respond to standard lifestyle advice. AA carriers of rs7571842 have a specific renal mechanism that amplifies the blood-pressure response to dietary sodium — standard guidelines recommending 2,300 mg/day may not adequately protect this group. The evidence from Carey et al. and Pilic & Mavrommatis consistently points to a substantially greater blood pressure benefit from stricter sodium restriction (targeting ≤1,500 mg/day, the threshold already recommended for people with established hypertension) compared to carriers of the protective G allele.

Tracking 24-hour urine sodium excretion is the most accurate way to quantify actual intake — spot urine sodium or diary estimates consistently underestimate consumption by 30–50%. Ambulatory blood pressure monitoring captures the salt-loading effect that clinic readings miss.

Interactions

rs7571842 and the nearby rs10177833 (also in SLC4A5, ~3 kb upstream) showed comparable effect sizes and were the two strongest SLC4A5 signals in the Carey 2012 study. Both SNPs are in partial linkage disequilibrium; compound effects in individuals carrying risk alleles at both sites have not been fully characterized. Future compound action candidates exist between rs7571842 and rs10177833.